Blueprint Medicines Corp (BPMC)

107.19 +0.19 (+0.18%) USD  |  NASDAQ  |  May 03, 16:00
107.20 +0.01 (+0.01%) After-Hours: 20:00
More

Blueprint Medicines Cash and Short Term Investments (Quarterly): 710.64M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
December 31, 2023 710.64M
September 30, 2023 712.98M
June 30, 2023 722.63M
March 31, 2023 822.16M
December 31, 2022 944.99M
September 30, 2022 1.137B
June 30, 2022 853.11M
March 31, 2022 586.83M
December 31, 2021 477.11M
September 30, 2021 701.88M
June 30, 2021 628.35M
March 31, 2021 851.96M
December 31, 2020 871.85M
September 30, 2020 757.43M
June 30, 2020 521.80M
March 31, 2020 666.76M
December 31, 2019 483.55M
September 30, 2019 493.44M
June 30, 2019 592.86M
Date Value
March 31, 2019 415.86M
December 31, 2018 494.01M
September 30, 2018 559.64M
June 30, 2018 613.46M
March 31, 2018 607.32M
December 31, 2017 673.36M
September 30, 2017 390.65M
June 30, 2017 421.01M
March 31, 2017 206.40M
December 31, 2016 214.16M
September 30, 2016 152.54M
June 30, 2016 172.55M
March 31, 2016 191.51M
December 31, 2015 162.71M
September 30, 2015 179.78M
June 30, 2015 193.59M
March 31, 2015 50.30M
December 31, 2014 47.24M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

477.11M
Minimum
Dec 2021
1.137B
Maximum
Sep 2022
712.49M
Average
710.64M
Median
Dec 2023

Cash and Short Term Investments (Quarterly) Benchmarks

Apellis Pharmaceuticals Inc 351.18M
Alnylam Pharmaceuticals Inc 2.371B
Ionis Pharmaceuticals Inc 2.331B
Madrigal Pharmaceuticals Inc 634.13M
Sarepta Therapeutics Inc 1.391B